Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07487844 | Pulsed Electric Field Ablation for Metastatic Breast Cancer | recruiting | N/A | 20 | University of California, San FranciscoOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT07676383 | Precision Navigation to Improve Community Cancer Screening Participation | recruiting | N/A | 1,500 | Hunan Cancer HospitalOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT07705334 |
| A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors(Luca-1) |
| recruiting |
| Phase 1 |
| 30 |
| SHY TherapeuticsINDUSTRY |
| 1 |
| Sep 18, 2026 |
| clinicaltrials |
| NCT04889924 | ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer(ADARNAT) | recruiting | N/A | 820 | Hospital Universitari de BellvitgeOTHER | 2 | Sep 17, 2026 | clinicaltrials |
| NCT05763641 | TAD After Chemotherapy in Locally Advanced Breast Cancer | recruiting | — | 162 | Hospital Universitari de BellvitgeOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT05782686 | Impact of Systematic Shaving on Margins | recruiting | N/A | 234 | Hospital Universitari de BellvitgeOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT06339658 | ICG vs Blue Patent for TAD in cN1 Breast Carcinoma After Neoadjuvant Chemotherapy | recruiting | — | 43 | Hospital Universitari de BellvitgeOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT06362616 | Preoperative Accelerated Partial Breast Irradiation in Patients With Locally Recurrent or Second Primary Breast Cancer(PAPBI-3) | recruiting | N/A | 31 | The Netherlands Cancer InstituteOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT06916637 | Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer | recruiting | — | 40 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT07020117 | A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors | recruiting | Phase 1 | 150 | Aktis Oncology, Inc.INDUSTRY | 1 | Sep 17, 2026 | clinicaltrials |
| NCT07109726 | A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations | recruiting | Phase 1 / Phase 2 | 205 | Terremoto Biosciences Inc.INDUSTRY | 4 | Sep 17, 2026 | clinicaltrials |
| NCT07297667 | GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours | recruiting | Phase 1 | 30 | Canadian Cancer Trials GroupNETWORK | 1 | Sep 17, 2026 | clinicaltrials |
| NCT07505797 | ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health(AUDIBLE) | recruiting | — | 800 | iSono Health, Inc.INDUSTRY | 1 | Sep 17, 2026 | clinicaltrials |
| NCT07685938 | Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease | recruiting | Phase 2 | 60 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT07826338 | Artificial Intelligence-supported Mobile Application for Patients With Breast Cancer | recruiting | N/A | 70 | Ege UniversityOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT04273061 | Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity(CAPTIV-8) | recruiting | Phase 2 | 50 | British Columbia Cancer AgencyOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT05142787 | Magseed Pro(R)/ Sentimag(R) Gen3 | recruiting | N/A | 224 | Endomagnetics Ltd.INDUSTRY | 2 | Sep 16, 2026 | clinicaltrials |
| NCT06324357 | Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread | recruiting | Phase 1 / Phase 2 | 768 | Boehringer IngelheimINDUSTRY | 10 | Sep 16, 2026 | clinicaltrials |
| NCT06353997 | Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients | recruiting | Phase 2 | 12 | Providence Health & ServicesOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT06780176 | A Study of Breast Cancer Risk Factors and Outcomes of People in Florida | recruiting | — | 800 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT07070791 | Combined Upper Extremity Resistance and Aerobic Exercise Training in Patients With Breast Cancer | recruiting | N/A | 40 | Hacettepe UniversityOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT07277738 | Precision Supplemental Imaging in Women With Dense Breasts(PSID) | recruiting | N/A | 78 | Washington University School of MedicineOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT07588425 | Cardiac Side Effects of Systemic Therapy in Early-Stage Breast Cancer(C-BREAST-01) | recruiting | — | 100 | Fatih GURLEROTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT07823660 | Cardio-Oncology Rehabilitation in Breast Cancer Patients Undergoing Chemotherapy | recruiting | N/A | 30 | Hospital de Clinicas de Porto AlegreOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT04362826 | Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer | recruiting | N/A | 100 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT04373655 | AXillary Surgery After NeoAdjuvant Treatment(AXSANA) | recruiting | — | 3,000 | European Breast Cancer Research Association of Surgical TrialistsNETWORK | 1 | Sep 15, 2026 | clinicaltrials |
| NCT04585750 | The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) | recruiting | Phase 1 / Phase 2 | 300 | PMV Pharmaceuticals, IncINDUSTRY | 9 | Sep 15, 2026 | clinicaltrials |
| NCT05115474 | Study of Screening Brain MRIs in Stage IV Breast Cancer | recruiting | Phase 2 | 170 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT05512364 | Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)(TREAT ctDNA) | recruiting | Phase 3 | 220 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Sep 15, 2026 | clinicaltrials |
| NCT05559411 | MEthods for LOcalization of Different Types of Breast Lesions(MELODY) | recruiting | — | 7,416 | European Breast Cancer Research Association of Surgical TrialistsNETWORK | 1 | Sep 15, 2026 | clinicaltrials |
| NCT05739591 | Long-term Safety and Efficacy of GBG Study Participants(ETERNITY) | recruiting | — | 400 | GBG Forschungs GmbHOTHER | 2 | Sep 15, 2026 | clinicaltrials |
| NCT05906407 | COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer(COGNITION) | recruiting | — | 2,000 | German Cancer Research CenterOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT06351865 | Feasibility Study to Evaluate the Use of Patient Reported Complications After Digital Consent(PRC) | recruiting | — | 50 | Portsmouth Hospitals NHS TrustOTHER_GOV | 1 | Sep 15, 2026 | clinicaltrials |
| NCT06492616 | A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence(ELEGANT) | recruiting | Phase 3 | 4,220 | Stemline Therapeutics, Inc.INDUSTRY | 28 | Sep 15, 2026 | clinicaltrials |
| NCT07009093 | Utility of a Mobile Application for Young Women With Breast Cancer | recruiting | N/A | 120 | Wake Forest University Health SciencesOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07341737 | SL-28 for Advanced Solid Tumours | recruiting | Phase 1 / Phase 2 | 60 | Second Life TherapeuticsINDUSTRY | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07418060 | Evaluation of the Impact of Pre-habilitation Using Physiotherapy and Mechanical Stimulation on Shoulder Pain and Mobility in Patients Undergoing Breast Reconstruction Using a Latissimus Dorsi Flap(PREHAB KINELGD) | recruiting | N/A | 96 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07429487 | Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer(WATCH AND ACT) | recruiting | N/A | 98 | Centre Antoine LacassagneOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07513311 | A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer(RESTORE) | recruiting | N/A | 75 | Massachusetts General HospitalOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07681323 | Timing of ctDNA Testing in Advanced Breast Cancer(TIMING) | recruiting | — | 400 | Geneplus-Beijing Co. Ltd.INDUSTRY | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07686250 | Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery | recruiting | Phase 2 | 37 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07702292 | [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications | recruiting | Phase 2 | 71 | Blue Earth DiagnosticsINDUSTRY | 2 | Sep 15, 2026 | clinicaltrials |
| NCT07796880 | Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive， Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer | recruiting | Phase 2 | 80 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT04090567 | Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer | recruiting | Phase 2 | 60 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 14, 2026 | clinicaltrials |
| NCT04660435 | To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer(TIRESIAS) | recruiting | — | 150 | Fondazione Sandro PitiglianiOTHER | 1 | Sep 14, 2026 | clinicaltrials |
| NCT05059444 | ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation(ORACLE) | recruiting | — | 2,285 | Guardant Health, Inc.INDUSTRY | 5 | Sep 14, 2026 | clinicaltrials |
| NCT06246968 | A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer | recruiting | Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 14, 2026 | clinicaltrials |
| NCT06727227 | Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer(EXPLORE) | recruiting | — | 138 | AstraZenecaINDUSTRY | 2 | Sep 14, 2026 | clinicaltrials |
Data updated 12 days agoSource updated Sep 18, 2026source: clinicaltrials